Vera Bril

1983–2025 年に発表

144
論文数
20,089
被引用数
75
h 指数
137
i10 指数

被引用数

Vera Bril の年別被引用数1975 年: 被引用 1 件1985 年: 被引用 2 件1986 年: 被引用 3 件1987 年: 被引用 4 件1988 年: 被引用 6 件1989 年: 被引用 6 件1990 年: 被引用 12 件1991 年: 被引用 9 件1992 年: 被引用 11 件1993 年: 被引用 3 件1994 年: 被引用 9 件1995 年: 被引用 14 件1996 年: 被引用 6 件1997 年: 被引用 11 件1998 年: 被引用 10 件1999 年: 被引用 15 件2000 年: 被引用 19 件2001 年: 被引用 22 件2002 年: 被引用 15 件2003 年: 被引用 27 件2004 年: 被引用 33 件2005 年: 被引用 43 件2006 年: 被引用 65 件2007 年: 被引用 74 件2008 年: 被引用 69 件2009 年: 被引用 93 件2010 年: 被引用 72 件2011 年: 被引用 77 件2012 年: 被引用 79 件2013 年: 被引用 108 件2014 年: 被引用 110 件2015 年: 被引用 113 件2016 年: 被引用 88 件2017 年: 被引用 108 件2018 年: 被引用 131 件2019 年: 被引用 581 件2020 年: 被引用 682 件2021 年: 被引用 697 件2022 年: 被引用 592 件2023 年: 被引用 489 件2024 年: 被引用 1,008 件2025 年: 被引用 481 件2026 年: 被引用 11 件1976〜1984 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,330 件、この内訳の 21.6%イギリス: 引用元論文 592 件、この内訳の 9.6%中国: 引用元論文 458 件、この内訳の 7.4%ドイツ: 引用元論文 393 件、この内訳の 6.4%イタリア: 引用元論文 340 件、この内訳の 5.5%カナダ: 引用元論文 270 件、この内訳の 4.4%オランダ: 引用元論文 206 件、この内訳の 3.3%日本: 引用元論文 200 件、この内訳の 3.3%オーストラリア: 引用元論文 189 件、この内訳の 3.1%フランス: 引用元論文 179 件、この内訳の 2.9%スペイン: 引用元論文 148 件、この内訳の 2.4%デンマーク: 引用元論文 142 件、この内訳の 2.3%
0%21.6%その他 27.8%

分野

  • Medicine83%
  • Biochemistry, Genetics and Molecular Biology8.5%
  • Neuroscience2.7%
  • Immunology and Microbiology2.1%
  • Health Professions1%
  • Engineering0.8%
  • その他1.9%

トピック

  • Pain Mechanisms and Treatments9.5%
  • Peripheral Neuropathies and Disorders6.4%
  • Myasthenia Gravis and Thymoma6.1%
  • Diabetic Foot Ulcer Assessment and Management3.8%
  • Botulinum Toxin and Related Neurological Disorders3.2%
  • Peripheral Nerve Disorders2.4%
  • その他68.6%

共著者

全論文

検索で開く
  1. Diabetic Neuropathy: A Position Statement by the American Diabetes Association

    著者: , , , , , , , - Diabetes Care 2016 被引用: 2,466

  2. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Angela Genge, Zaeem A. Siddiqi, Jana Junkerová, Jana Hořáková, Katerina Reguliova, Michaela Týblová, Ivana Jurajdova, Iveta Nováková, Michala Jakubíková, Jiří Piťha, Stanislav Voháňka, Katerina Havelkova, Tomáš Horák, Josef Bednařík, Mageda Horakova, Andreas Meisel, Dike Remstedt, Claudia Heibutzki, Siegfried Köhler, Lea Gerischer, Sarah Hoffman, Frauke Stascheit, John Vissing, Lizzie Zafirakos, Kuldeep Kumar Khatri, Anne Ostergaard Autzen, Mads Stemmerik, Henning Andersen, Shahram Attarian, Emmanuelle Salort‐Campana, Émilien Delmont, Aude‐Marie Grapperon, Ludivine Kouton, Alexander Tsiskaridze, Csilla Rózsa, Gedeonne Jakab, Szilvia Z. Tóth, G Szabó, David Bors, Enikő Szabó, Angela Campanella, Fiammetta Vanoli, Rita Frangiamore, Carlo Antozzi, Silvia Bonanno, Lorenzo Maggi, Riccardo Giossi, Francesco Saccà, Angela Marsili, Chiara Pane, Giorgia Puorro, Antonio Reia, Giovanni Antonini, Girolamo Alfieri, Stefania Morino, Matteo Garibaldi, Laura Fionda, Luca Leonardi, Shingo Konno, Akiyuki Uzawa, Kaoru Sakuma, Chiho Watanabe, Yukiko Ozawa, Manato Yasuda, Yosuke Onishi, Makoto Samukawa, Tomoko Tsuda, Yasushi Suzuki, Sayaka Ishida, Genya Watanabe ほか 118 名 - The Lancet Neurology 2021 被引用: 668

  3. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julia Wanschitz, Wolfgang N. Löscher, Jan De Bleecker, Guy Van den Abeele, Kathy de Koning, Katrien De Mey, Rudy Mercelis, Linda Wagemaekers, Délphine Mahieu, Philip Van Damme, Charlotte Smetcoren, Olivier Stevens, Sarah Verjans, Ann D’Hondt, Petra Tilkin, Alzira Alves de Siqueira Carvalho, Rosa Hasan, Igor Dias Brockhausen, David Feder, Daniel Ambrosio, Ana Paula Souto Melo, Rosana Rocha, Bruno Bezerra Rosa, Thabata Veiga, Luiz Augusto da Silva, Jordana Gonçalves Geraldo, Maria da Penha Morita Ananias, Érica Nogueira Coelho, Gabriel Pina Paiva, M Tovar Pozo, Natália Prando, Debora Dada Martineli Torres, Cristiani Fernanda Butinhao, Érica Nogueira Coelho, Luciana Renata Cubas Volpe, Gustavo Duran, Tamires Cristina Gomes da Silva, Luiz Otavio Maia Gonçalves, Lucas Eduardo Pazetto, Luciana Souza Duca, Tomás Augusto Suriane Fialho, Maurício Friedrich, Alexandre Guerreiro, Henrique Mohr, Maurer Pereira Martins, Daiane da Cruz Pacheco, Ana Paula Macagnan, Aline de Cassia Santos, Acary Souza Bullé Oliveira, Ana Carolina Amaral de Andrade, Marcelo Annes, Valéria Cavalcante Lino, Wladimir Bocca Vieira de Rezende Pinto, Carolina Miranda, Fernanda Carrara, Iandra Souza, Angela Genge, Rami Massie, Natasha Campbell, Vera Bril, Hans Katzberg, Mehran Soltani, Eduardo Ng, Zaeem A. Siddiqi, Celile Phan, Derrick Blackmore, Stanislav Voháňka, Josef Bednařík, Magda Chmelikova, Marek Čierny ほか 524 名 - The Lancet Neurology 2017 被引用: 800

  4. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stéphan A. Botez, Michaela Týblová, Michala Jakubíková, Jana Junkerová, John Vissing, Nanna Witting, Sonja Holm‐Yildiz, Mads Stemmerik, Henning Andersen, Izabella Obál, Guilhem Solé, Stéphane Mathis, Marie‐Hélène Violleau, Christine Tranchant, Sihame Messai, Jean‐Baptiste Chanson, Aleksandra Nadaj‐Pakleza, Arnaud Verloes, Leila Zaidi, Sabrina Sacconi, Manuela Gambella, Michele Cavalli, Tanya Stojkovic, Sophie Demeret, Loïc Le Guennec, Giorgia Querin, Nicolas Weiss, Marion Masingue, Laurent Magy, Karima Ghorab, Ia Rukhadze, Alexander Tsiskaridze, Marina Janelidze, Temur Margania, Florian Then Bergh, Eike Hänsel, Andrea Kalb, Bianca Meilick, Mandy Reuschel, Lars-Malte Teußer, Astrid Unterlauft, Clemens Goedel, Tim Hagenacker, Andreas Totzeck, Benjamin Stolte, Franz Blaes, Christine Bindler, Vasilios Tsoutsikas, Annekathrin Roediger, Christian Geis, Jens Schmidt, Jana Zschüntzsch, Margret Schwarz, Stefanie Meyer, Karsten Kummer, Stefanie Glaubitz, Rachel Zeng, Heinz Wiendl, Luisa Klotz, Anna Lammerskitten, Jan D. Lünemann, Péter Diószeghy, Renato Mantegazza, Lorenzo Maggi, Elena Rinaldi, Matteo Gastaldi, Federico Mazzacane, Pietro Businaro, Raffaele Iorio, Giovanni Antonini ほか 193 名 - The Lancet Neurology 2023 被引用: 260

  5. Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , NEURO-TTRansform Investigators, Anna Mazzeo, Aikaterini Papagianni, Mazen M. Dimachkie, Ioannis Zaganas, Edward Gane, Marco Luigetti, Lucía Galán Dávila, Michelle M. Mezei, Juan González Moreno, Pascal Cintas, Davide Pareyson, Rebecca Traub, Julie Khoury, Conrado J. Estol, Merrilee Needham, David Adams, Michael Polydefkis, Thomas H. Brannagan, Vera Bril, Shahram Attarian, Marcelo Rugiero, B. Jane Distad, Eleni Zamba Papanicolaou, Kon‐Ping Lin, Merrill D. Benson, Morton Scheinberg - JAMA 2023 被引用: 207

  6. Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jerrica Farias, Rita Frangiomore, Sarah Heintsman, Robert H.P. de Meel, Manisha Chopra, Paolo Emilio Alboini, Angela Genge - Neurology 2019 被引用: 288

  7. Pharmacotherapy of Generalized Myasthenia Gravis with Special Emphasis on Newer Biologicals

    著者: , - Drugs 2022 被引用: 129

  8. Efficacy and Safety of Rozanolixizumab in Moderate to Severe Generalized Myasthenia Gravis

    著者: , , , , , , , , , , - Neurology 2020 被引用: 140

  9. Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis

    著者: , , , , , , , , , , , , , , , , , - Frontiers in Neurology 2024 被引用: 71

  10. Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary

    著者: , , , , , , , , , , , , , , , , , , - Neurology 2021 被引用: 167

  11. Diabetic Neuropathies

    著者: , , , , , , , , , - Diabetes Care 2005 被引用: 1,836

  12. International clinimetric evaluation of the MG‐QOL15, resulting in slight revision and subsequent validation of the MG‐QOL15r

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Muscle & Nerve 2016 被引用: 156

  13. Advances and ongoing research in the treatment of autoimmune neuromuscular junction disorders

    著者: , , , , , - The Lancet Neurology 2022 被引用: 108

  14. Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis

    著者: , , , , , , , , , , , , , , , , - Neurology 2023 被引用: 72

  15. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity

    著者: , , , , , , , , , , - Diabetes/Metabolism Research and Reviews 2011 被引用: 492

  16. Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Silvia Bonanno, Angela Campanella, Tiyonnoh Cash, Bakri Elsheikh, Vittorio Frasca, Namita Goyal, Brittany Harvey, Eugene C. Lai, Lorenzo Maggi, Brian Minton, Verónica Puertas‐Martín, Emanuela Onesti, Mamatha Pasnoor, Gulmohor Roy, Sheetal Shroff, Jason R. Thonhoff - Neurology 2018 被引用: 128

  17. Evidence-based guideline: Treatment of painful diabetic neuropathy [RETIRED]

    著者: , , , , , , , , , , - Neurology 2011 被引用: 630

  18. Comparison of IVIg and PLEX in patients with myasthenia gravis

    著者: , , , , - Neurology 2011 被引用: 351

  19. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Toomas Toomsoo, Inna Rubanovits, Katrin Gross‐Paju, Ulvi Sorro, M. Saarela, Mari Auranen, Jean Pouget, Shahram Attarian, Gwendal Le Masson, Anne-Cécile Wielanek-Bachelet, Claude Desnuelle, Émilien Delmont, Pierre Clavelou, D Aufauvre, Jens Schmidt, Jana Zschuentssch, Claudia Sommer, Daniela Kramer, Olaf Hoffmann, Carsten Goerlitz, Jürgen Haas, Marios Chatzopoulos, Richard S. Yoon, Ralf Gold, Peter Berlit, Andrea Jaspert-Grehl, David Liebetanz, Anna Kutschenko, Martin Stangel, Corinna Trebst, Petra Baum, Florian Then Bergh, Juliane Klehmet, Andreas Meisel, Fabian Klostermann, Johanna Oechtering, Helmar C. Lehmann, Michael Schroeter, Tim Hagenacker, Daniel Mueller, A.D Sperfeld, F. Bethke, Vivian E. Drory, Avi A. Algom, David Yarnitsky, Beth B. Murinson, Antonio Di Muzio, Fausta Ciccocioppo, Sandro Sorbi, Sabrina Matà, Angelo Schenone, Marina Grandis, Giuseppe Lauria, Daniele Cazzato, Giovanni Antonini, Stefania Morino, Dario Cocito, Maurizio Zibetti, Takanori Yokota, Takuya Ohkubo, Takashi Kanda, M Kawai, Kenichi Kaida, Hiroyuki Onoue, Satoshi Kuwabara, Masahiro Mori, Masahiro Iijima, Ken Ohyama, Masayuki Baba, Masahiko Tomiyama ほか 50 名 - The Lancet Neurology 2017 被引用: 269

  20. Validation of the Toronto Clinical Scoring System for Diabetic Polyneuropathy

    著者: , - Diabetes Care 2002 被引用: 457

  21. Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial

    著者: , , , , , , , , , - The Lancet Neurology 2008 被引用: 669

  22. Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy

    著者: , , , , - Diabetic Medicine 2009 被引用: 220

  23. Novel Treatments in Myasthenia Gravis

    著者: , , - Frontiers in Neurology 2020 被引用: 101

  24. The genomic landscape of schwannoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2016 被引用: 188